These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25512615)

  • 21. TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer.
    Takayama KI; Suzuki T; Tanaka T; Fujimura T; Takahashi S; Urano T; Ikeda K; Inoue S
    Oncogene; 2018 Apr; 37(16):2165-2180. PubMed ID: 29379164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aurora Kinase A Promotes AR Degradation via the E3 Ligase CHIP.
    Sarkar S; Brautigan DL; Larner JM
    Mol Cancer Res; 2017 Aug; 15(8):1063-1072. PubMed ID: 28536143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reciprocal deregulation of NKX3.1 and AURKA axis in castration-resistant prostate cancer and NEPC models.
    Sooreshjani MA; Kamra M; Zoubeidi A; Shah K
    J Biomed Sci; 2021 Oct; 28(1):68. PubMed ID: 34625072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma.
    Tan HL; Sood A; Rahimi HA; Wang W; Gupta N; Hicks J; Mosier S; Gocke CD; Epstein JI; Netto GJ; Liu W; Isaacs WB; De Marzo AM; Lotan TL
    Clin Cancer Res; 2014 Feb; 20(4):890-903. PubMed ID: 24323898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma.
    Fornari F; Milazzo M; Galassi M; Callegari E; Veronese A; Miyaaki H; Sabbioni S; Mantovani V; Marasco E; Chieco P; Negrini M; Bolondi L; Gramantieri L
    Mol Cancer Res; 2014 Feb; 12(2):203-16. PubMed ID: 24324033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological and genetic analyses of small cell neuroendocrine carcinoma of the prostate: Histological features for accurate diagnosis and toward future novel therapies.
    Ida A; Okubo Y; Kasajima R; Washimi K; Sato S; Yoshioka E; Osaka K; Suzuki T; Yamamoto Y; Yokose T; Kishida T; Miyagi Y
    Pathol Res Pract; 2022 Jan; 229():153731. PubMed ID: 34952423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53-Altered FBXW7 expression determines poor prognosis in gastric cancer cases.
    Yokobori T; Mimori K; Iwatsuki M; Ishii H; Onoyama I; Fukagawa T; Kuwano H; Nakayama KI; Mori M
    Cancer Res; 2009 May; 69(9):3788-94. PubMed ID: 19366810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-199a-3p inhibits aurora kinase A and attenuates prostate cancer growth: new avenue for prostate cancer treatment.
    Qu Y; Huang X; Li Z; Liu J; Wu J; Chen D; Zhao F; Mu D
    Am J Pathol; 2014 May; 184(5):1541-9. PubMed ID: 24631181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway.
    Wang H; Yang Z; Liu C; Huang S; Wang H; Chen Y; Chen G
    Biochem Biophys Res Commun; 2014 Nov; 454(1):71-7. PubMed ID: 25445601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.
    Beltran H; Rickman DS; Park K; Chae SS; Sboner A; MacDonald TY; Wang Y; Sheikh KL; Terry S; Tagawa ST; Dhir R; Nelson JB; de la Taille A; Allory Y; Gerstein MB; Perner S; Pienta KJ; Chinnaiyan AM; Wang Y; Collins CC; Gleave ME; Demichelis F; Nanus DM; Rubin MA
    Cancer Discov; 2011 Nov; 1(6):487-95. PubMed ID: 22389870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine Carcinoma.
    Li W; Cohen A; Sun Y; Squires J; Braas D; Graeber TG; Du L; Li G; Li Z; Xu X; Chen X; Huang J
    Mol Cancer Res; 2016 Apr; 14(4):344-53. PubMed ID: 26832214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC.
    Duan L; Perez RE; Calhoun S; Maki CG
    Sci Rep; 2022 Jan; 12(1):1049. PubMed ID: 35058503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-transcriptional Gene Regulation by MicroRNA-194 Promotes Neuroendocrine Transdifferentiation in Prostate Cancer.
    Fernandes RC; Toubia J; Townley S; Hanson AR; Dredge BK; Pillman KA; Bert AG; Winter JM; Iggo R; Das R; Obinata D; ; Sandhu S; Risbridger GP; Taylor RA; Lawrence MG; Butler LM; Zoubeidi A; Gregory PA; Tilley WD; Hickey TE; Goodall GJ; Selth LA
    Cell Rep; 2021 Jan; 34(1):108585. PubMed ID: 33406413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pten regulates Aurora-A and cooperates with Fbxw7 in modulating radiation-induced tumor development.
    Kwon YW; Kim IJ; Wu D; Lu J; Stock WA; Liu Y; Huang Y; Kang HC; DelRosario R; Jen KY; Perez-Losada J; Wei G; Balmain A; Mao JH
    Mol Cancer Res; 2012 Jun; 10(6):834-44. PubMed ID: 22513362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CDCA2 promotes melanoma progression by inhibiting ubiquitin-mediated degradation of Aurora kinase A.
    Sun W; Jin Y; Wei C; Xu Y; Liu W; Zhong J; Zou Z; Lin X; Xiang Y; Chen Y
    Eur J Cancer; 2023 Jul; 188():49-63. PubMed ID: 37196484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
    Wu Z; He B; He J; Mao X
    Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gliomagenesis arising from Pten- and Ink4a/Arf-deficient neural progenitor cells is mediated by the p53-Fbxw7/Cdc4 pathway, which controls c-Myc.
    Kim HS; Woolard K; Lai C; Bauer PO; Maric D; Song H; Li A; Kotliarova S; Zhang W; Fine HA
    Cancer Res; 2012 Nov; 72(22):6065-75. PubMed ID: 22986743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The sensitivity of gastric cancer to trastuzumab is regulated by the miR-223/FBXW7 pathway.
    Eto K; Iwatsuki M; Watanabe M; Ishimoto T; Ida S; Imamura Y; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Baba H
    Int J Cancer; 2015 Apr; 136(7):1537-45. PubMed ID: 25159729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via p53-independent mechanisms.
    Kovacevic Z; Sivagurunathan S; Mangs H; Chikhani S; Zhang D; Richardson DR
    Carcinogenesis; 2011 May; 32(5):732-40. PubMed ID: 21398495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MYBL2 Drives Prostate Cancer Plasticity: Inhibiting Its Transcriptional Target CDK2 for RB1-Deficient Neuroendocrine Prostate Cancer.
    German B; Alaiwi SA; Ho KL; Nanda JS; Fonseca MA; Burkhart DL; Sheahan AV; Bergom HE; Morel KL; Beltran H; Hwang JH; Freedman ML; Lawrenson K; Ellis L
    Cancer Res Commun; 2024 Sep; 4(9):2295-2307. PubMed ID: 39113611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.